Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000019617-25-000496·JPMORGAN CHASE & CO
Schedule 13G ownership disclosure
REGENERON PHARMACEUTICALS COM
Common Stock - par value $.001 per share · CUSIP: 75886F107
Event date: 2025-05-30
- Filing-level shares
- 4,742,611.0
- Percent of class
- 4.4%
- JPMORGAN CHASE & CO.
Shares: 4,742,611.0 · Class: 4.4%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000019617-25-000496
- Form type
- SCHEDULE 13G/A
- Filer
- JPMORGAN CHASE & CO
- CIK
- CIK 19617
- Filed
- Jun 05, 2025
- Reporting period
- May 30, 2025
- Description
- Schedule 13G beneficial ownership